Get started
Author

Anthony W. Gebhard

Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent Kinases
2013 · Ernst Schonbrunn, Stephane Betzi, et al. · Journal of Medicinal Chemistry · 89
Acquisition of Resistance toward HYD1 Correlates with a Reduction in Cleaved α4 Integrin Expression and a Compromised CAM-DR Phenotype
2011 · Michael F. Emmons, Anthony W. Gebhard, et al. · Molecular Cancer Therapeutics · 29
MTI-101 (Cyclized HYD1) Binds a CD44 Containing Complex and Induces Necrotic Cell Death in Multiple Myeloma
2013 · Anthony W. Gebhard, Priyesh Jain, et al. · Molecular Cancer Therapeutics · 27
Genetic Association of Nonsynonymous Variants of the IL23R with Familial and Sporadic Inflammatory Bowel Disease in Women
2009 · Zhenwu Lin, Lisa Poritz, et al. · Digestive Diseases and Sciences · 23
Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis
2017 · Swetha Tati, John C. Fisk, et al. · Neoplasia · 17
Genetic Association of DLG5 R30Q with Familial and Sporadic Inflammatory Bowel Disease in Men
2009 · Z. Lin, L. Poritz, et al. · Disease Markers · 13
PDF
Emerging Strategies for Targeting Cell Adhesion in Multiple Myeloma
2012 · Rajesh R. Nair, Anthony W. Gebhard, et al. · Advances in pharmacology · 12
Bioactivity improvement via display of the hydrophobic core of HYD1 in a cyclic β‐hairpin ‐like scaffold, MTI ‐101
2020 · Priyesh Jain, David B. Badger, et al. · Peptide Science · 4
PDF
Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733]
2017 · Swetha Tati, John C. Fisk, et al. · Neoplasia · 2
PDF
Supplementary Figures 1 - 7 from MTI-101 (Cyclized HYD1) Binds a CD44 Containing Complex and Induces Necrotic Cell Death in Multiple Myeloma
2023 · Anthony W. Gebhard, Priyesh Jain, et al.
PDF
Supplementary Figure Legend from MTI-101 (Cyclized HYD1) Binds a CD44 Containing Complex and Induces Necrotic Cell Death in Multiple Myeloma
2023 · Anthony W. Gebhard, Priyesh Jain, et al.
Data from MTI-101 (Cyclized HYD1) Binds a CD44 Containing Complex and Induces Necrotic Cell Death in Multiple Myeloma
2023 · Anthony W. Gebhard, Priyesh Jain, et al.
Supplementary Figures 1 - 7 from MTI-101 (Cyclized HYD1) Binds a CD44 Containing Complex and Induces Necrotic Cell Death in Multiple Myeloma
2023 · Anthony W. Gebhard, Priyesh Jain, et al.
Data from MTI-101 (Cyclized HYD1) Binds a CD44 Containing Complex and Induces Necrotic Cell Death in Multiple Myeloma
2023 · Anthony W. Gebhard, Priyesh Jain, et al.
Supplementary Figure Legend from MTI-101 (Cyclized HYD1) Binds a CD44 Containing Complex and Induces Necrotic Cell Death in Multiple Myeloma
2023 · Anthony W. Gebhard, Priyesh Jain, et al.
PDF
Data from Acquisition of Resistance toward HYD1 Correlates with a Reduction in Cleaved α4 Integrin Expression and a Compromised CAM-DR Phenotype
2023 · Michael F. Emmons, Anthony W. Gebhard, et al.
Supplementary Methods, Figures 1-3, Table 1 from Acquisition of Resistance toward HYD1 Correlates with a Reduction in Cleaved α4 Integrin Expression and a Compromised CAM-DR Phenotype
2023 · Michael F. Emmons, Anthony W. Gebhard, et al.
PDF
Supplementary Methods, Figures 1-3, Table 1 from Acquisition of Resistance toward HYD1 Correlates with a Reduction in Cleaved α4 Integrin Expression and a Compromised CAM-DR Phenotype
2023 · Michael F. Emmons, Anthony W. Gebhard, et al.
Data from Acquisition of Resistance toward HYD1 Correlates with a Reduction in Cleaved α4 Integrin Expression and a Compromised CAM-DR Phenotype
2023 · Michael F. Emmons, Anthony W. Gebhard, et al.
CD44 containing complexes as a therapeutic target in Multiple Myeloma
2013 · Anthony W. Gebhard · Digital Commons - University of South Florida (University of South Florida)
PDF
Emerging Opportunities for Targeting the Tumor–Stroma Interactions for Increasing the Efficacy of Chemotherapy
2012 · Rajesh R. Nair, Anthony W. Gebhard, et al. · Springer eBooks
Mti-101 (cyclized HYD1) Binds to CD44 and Induces Necrotic Cell Death in Multiple Myeloma
2012 · Anthony W. Gebhard, Rajesh R Nair, et al. · Blood
Abstract 1523: α4 integrin expression is a determinant for activity of the integrin antagonist HYD1 in multiple myeloma cell lines and patient specimens
2011 · Michael F. Emmons, Anthony Gebhard, et al. · Cancer Research
Abstract 3628: The forced interaction of α4 integrin and CD44 by the novel peptide HYD1 may be a determinant of HYD1-induced cell death in multiple myeloma
2011 · Anthony W. Gebhard, Michael F. Emmons, et al. · Cancer Research
M2074 OCTN1 L503F Variant Is Associated with Inflammatory Bowel Disease (IBD) in Familial and Sporadic IBD
2008 · Zhenwu Lin, Laurie S. Nelson, et al. · Gastroenterology
Works count: 27
Citation count: 216
H-index: 7
I10-index: 7
Year
Topic
Type